Zeitschriftenartikel zum Thema „Cytogenetics“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Cytogenetics" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Vance, Gail H., Haesook Kim, Gary Hicks, Athena Cherry, Rodney Higgins, Martin S. Tallman, Hugo F. Fernandez und Gordon Dewald. „Utility of Interphase FISH To Stratify Patients into Cytogenetic Risk Categories at Diagnosis of AML in an ECOG Clinical Trial (E1900).“ Blood 106, Nr. 11 (16.11.2005): 2377. http://dx.doi.org/10.1182/blood.v106.11.2377.2377.
Chennamaneni, Rachana, Sadashivudu Gundeti, Meher Lakshmi Konatam, Stalin Bala, Ashok Kumar und Lakshmi Srinivas. „Impact of cytogenetics on outcomes in pediatric acute lymphoblastic leukemia“. South Asian Journal of Cancer 07, Nr. 04 (Oktober 2018): 263–66. http://dx.doi.org/10.4103/sajc.sajc_13_18.
Koenecke, Christian, Gudrun Göhring, Liesbeth de Wreede, Anja van Biezen, Christof Scheid, Liisa Volin, Johan Maertens et al. „Prognostic Value Of Five-Group Cytogenetic Risk Classification In Patients With MDS After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Multicenter Study Of The Chronic Malignancies Working Party Of The EBMT“. Blood 122, Nr. 21 (15.11.2013): 2092. http://dx.doi.org/10.1182/blood.v122.21.2092.2092.
Kim, Sung-Yong, Jong-Wook Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Chang-Ki Min et al. „Clinical Implications of Abnormal Cytogenetics at Diagnosis of Aplastic Anemia.“ Blood 108, Nr. 11 (16.11.2006): 986. http://dx.doi.org/10.1182/blood.v108.11.986.986.
Kim, Sung-Yong, Myungshin Kim, Kyungja Han, Seok Lee, Mark Hong Lee, Jong-Wook Lee, Woo-Sung Min und Chun-Choo Kim. „Characteristics and Clinical Outcomes of Adult Aplastic Anemia with Abnormal Cytogenetics at Diagnosis.“ Blood 112, Nr. 11 (16.11.2008): 2039. http://dx.doi.org/10.1182/blood.v112.11.2039.2039.
Larson, Melissa L., Ann M. Thomas, Nitin Goyal, Jamile M. Shammo, John J. Maciejewski, Stephanie A. Gregory und Parameswaran Venugopal. „Efficacy of a Two Day Induction Regimen for De Novo and Secondary AML with Intermediate and Adverse Cytogenetic Profiles“. Blood 112, Nr. 11 (16.11.2008): 4027. http://dx.doi.org/10.1182/blood.v112.11.4027.4027.
Zhang, Peng, Bernd Friebe, Bikram Gill und R. F. Park. „Cytogenetics in the age of molecular genetics“. Australian Journal of Agricultural Research 58, Nr. 6 (2007): 498. http://dx.doi.org/10.1071/ar07054.
JACKSON, LAIRD. „Cytogenetics and Molecular Cytogenetics“. Clinical Obstetrics and Gynecology 45, Nr. 3 (September 2002): 622–39. http://dx.doi.org/10.1097/00003081-200209000-00006.
Armand, Philippe, Haesook T. Kim, Daniel J. DeAngelo, Vincent T. Ho, Corey S. Cutler, Richard M. Stone, Jerome Ritz, Edwin P. Alyea, Joseph H. Antin und Robert J. Soiffer. „Impact of Cytogenetics and Prior Therapy on Outcome of AML and MDS after Allogeneic Transplantation.“ Blood 108, Nr. 11 (16.11.2006): 259. http://dx.doi.org/10.1182/blood.v108.11.259.259.
Rashidi, Armin, und Amanda F. Cashen. „A Cytogenetic Model Predicts Relapse Risk and Survival in Patients with Acute Myeloid Leukemia Undergoing Hematopoietic Stem Cell Transplantation in Morphologic Complete Remission“. Blood 124, Nr. 21 (06.12.2014): 2545. http://dx.doi.org/10.1182/blood.v124.21.2545.2545.
Mellors, Patrick, Moritz Binder, Rhett P. Ketterling, Patricia Griepp, Linda B. Baughn, Francis K. Buadi, Martha Q. Lacy et al. „Metaphase Cytogenetics for Risk Stratification in Newly Diagnosed Multiple Myeloma“. Blood 134, Supplement_1 (13.11.2019): 4396. http://dx.doi.org/10.1182/blood-2019-122291.
Bayani, Jane, Ajay Pandita und Jeremy A. Squire. „Molecular cytogenetic analysis in the study of brain tumors: findings and applications“. Neurosurgical Focus 19, Nr. 5 (November 2005): 1–36. http://dx.doi.org/10.3171/foc.2005.19.5.2.
Sachs, Zohar, Michelle Dollan, Todd E. De For, Leyla Shune, Sarah Cooley, Daniel J. Weisdorf, Erica D. Warlick und Celalettin Ustun. „Are IPSS-R and IPSS Cytogenetic Risk Stratification Informative At the Time of Allogeneic Hematopoietic Cell Transplantation?“ Blood 120, Nr. 21 (16.11.2012): 1400. http://dx.doi.org/10.1182/blood.v120.21.1400.1400.
Sproat, Lisa O., Brian Bolwell, Lisa Rybicki, Matt Kalaycio, Robert Dean, Ronald Sobecks, Brad Pohlman et al. „No Impact of Postremission Consolidation Chemotherapy Before Allogeneic Transplant in Patients with First Remission Acute Myeloid Leukemia with Intermediate or High Risk Cytogenetics.“ Blood 112, Nr. 11 (16.11.2008): 2164. http://dx.doi.org/10.1182/blood.v112.11.2164.2164.
Nishio, Jun. „Contributions of Cytogenetics and Molecular Cytogenetics to the Diagnosis of Adipocytic Tumors“. Journal of Biomedicine and Biotechnology 2011 (2011): 1–9. http://dx.doi.org/10.1155/2011/524067.
Li, Marilyn, und Daniel Pinkel. „Clinical cytogenetics and molecular cytogenetics“. Journal of Zhejiang University SCIENCE B 7, Nr. 2 (Februar 2006): 162–63. http://dx.doi.org/10.1631/jzus.2006.b0162.
Hall, K. J., J. S. Parker und T. H. N. Ellis. „The relationship between genetic and cytogenetic maps of pea. I. Standard and translocation karyotypes“. Genome 40, Nr. 5 (01.10.1997): 744–54. http://dx.doi.org/10.1139/g97-797.
Haase, Detlef, Ulrich Germing, Julie Schanz, Michael Pfeilstoecker, Barbara Hildebrandt, Michael Luebbert, Aristoteles Giagounidis et al. „Evidence for an Underestimation of the Prognostic Impact of Poor Cytogenetics within the IPSS.“ Blood 108, Nr. 11 (16.11.2006): 252. http://dx.doi.org/10.1182/blood.v108.11.252.252.
Klein, Kim, Martin Zimmermann, Berna Beverloo, Christine von Neuhoff, Valerie De Haas, Romy van Weelderen, Susana C. Raimondi et al. „The Prognostic Impact of Cytogenetics and Karyotype Changes in Pediatric Patients with Relapsed Acute Myeloid Leukemia: A Retrospective Cohort Study within the Relapsed AML 2001/01 Study“. Blood 128, Nr. 22 (02.12.2016): 2896. http://dx.doi.org/10.1182/blood.v128.22.2896.2896.
Kalaycio, Matt, Mikkael Sekeres, Ronald Sobecks, Lisa Rybicki, Brad Pohlman, Anjali Advani, Elizabeth Kuczkowski und Brian Bolwell. „Cytogenetic Classification Systems and Overall Survival Following Bone Marrow Transplant (BMT) for Acute Myelogenous Leukemia (AML).“ Blood 106, Nr. 11 (16.11.2005): 4500. http://dx.doi.org/10.1182/blood.v106.11.4500.4500.
&NA;. „Cytogenetics“. Journal of Pediatric Hematology/Oncology 25, Nr. 4 (April 2003): S14—S15. http://dx.doi.org/10.1097/00043426-200304000-00032.
Glassman, Armand B. „Cytogenetics“. Clinics in Laboratory Medicine 17, Nr. 1 (März 1997): 21–37. http://dx.doi.org/10.1016/s0272-2712(18)30229-4.
Mecucci, Cristina, und Herman Van den Berghe. „Cytogenetics“. Hematology/Oncology Clinics of North America 6, Nr. 3 (Juni 1992): 523–41. http://dx.doi.org/10.1016/s0889-8588(18)30326-5.
Astbury, Caroline. „Cytogenetics“. Clinics in Laboratory Medicine 31, Nr. 4 (Dezember 2011): xiii—xv. http://dx.doi.org/10.1016/j.cll.2011.08.017.
&NA;. „Cytogenetics“. Pathology 22 (1990): 25. http://dx.doi.org/10.3109/00313029009060109.
&NA;. „Cytogenetics“. Pathology 25, Suppl 1 (1993): 17–18. http://dx.doi.org/10.3109/00313029309107648.
Paner, Gladell P., Valerie Lindgren, Kris Jacobson, Kathleen Harrison, Ying Cao, Steve C. Campbell, Robert C. Flanigan und Maria M. Picken. „High Incidence of Chromosome 1 Abnormalities in a Series of 27 Renal Oncocytomas: Cytogenetic and Fluorescence In Situ Hybridization Studies“. Archives of Pathology & Laboratory Medicine 131, Nr. 1 (01.01.2007): 81–85. http://dx.doi.org/10.5858/2007-131-81-hiocai.
Meggendorfer, Manja, Tamara Alpermann, Karolina Perglerová, Wolfgang Kern, Susanne Schnittger, Claudia Haferlach und Torsten Haferlach. „Genetic Patterns of Relapsed AML Differ Significantly from First Manifestation and Are Dependent on Cytogenetic Risk Groups at Diagnosis: Results in 175 Patients with Paired Samples“. Blood 124, Nr. 21 (06.12.2014): 1029. http://dx.doi.org/10.1182/blood.v124.21.1029.1029.
Gangat, Naseema, Jacob J. Strand, Terra L. Lasho, Christy M. Finke, Ryan A. Knudson, Animesh Pardanani, Chin-Yang Li, Rhett P. Ketterling und Ayalew Tefferi. „Cytogenetic Studies at Diagnosis in Polycythemia Vera: Clinical and JAK2V617F Allele Burden Correlates.“ Blood 110, Nr. 11 (16.11.2007): 2545. http://dx.doi.org/10.1182/blood.v110.11.2545.2545.
Wolanskyj, Alexandra P., Naseema Gangat, Susan M. Schwager, Rhett P. Ketterling und Ayalew Tefferi. „Cytogenetic Abnormalities in Essential Thrombocythemia: Prevalence and Prognostic Significance.“ Blood 108, Nr. 11 (16.11.2006): 3626. http://dx.doi.org/10.1182/blood.v108.11.3626.3626.
Dingli, David, Schwager M. Schwager, Mesa A. Ruben, Chin Yang Li und Ayalew Tefferi. „Presence of Unfavorable Cytogenetic Abnormalities Is the Strongest Predictor of Poor Survival in Secondary Myelofibrosis.“ Blood 106, Nr. 11 (16.11.2005): 2585. http://dx.doi.org/10.1182/blood.v106.11.2585.2585.
Walter, Claudia Ulrike, Mouhab Ayas, Amal Alseraihy, Hassan El-Solh, Abdullah Al-Jefri, Ali Al-Ahmari, Asim F. Belgaumi und Maher Albitar. „Cytogenetic Risk Remains a Major Predictor of Outcome in Pediatric AML and ALL Treated with Allogeneic Stem Cell Transplantation“,. Blood 118, Nr. 21 (18.11.2011): 3524. http://dx.doi.org/10.1182/blood.v118.21.3524.3524.
Tamkus, Deimante, Ahmad Jajeh, Ebenezer Berko, David Osafo, Decebal Griza, Paula Kovarik und Rose Catchatourian. „Adult Acute Lymphoblastic Leukemia and Cytogenetic Abnormalities in Different Racial and Ethnic Subgroups.“ Blood 106, Nr. 11 (16.11.2005): 4547. http://dx.doi.org/10.1182/blood.v106.11.4547.4547.
Quessada, Julie, Wendy Cuccuini, Paul Saultier, Marie Loosveld, Christine J. Harrison und Marina Lafage-Pochitaloff. „Cytogenetics of Pediatric Acute Myeloid Leukemia: A Review of the Current Knowledge“. Genes 12, Nr. 6 (17.06.2021): 924. http://dx.doi.org/10.3390/genes12060924.
Najfeld, Vesna, Joseph Tripodi, Marina Kremanskaya, John Mascarenhas und Ronald Hoffman. „Peripheral Blood Karyotyping Is Superior To Bone Marrow and Identifies Most Frequent Structural Chromosomal Rearrangements In Myelofibrosis“. Blood 122, Nr. 21 (15.11.2013): 3727. http://dx.doi.org/10.1182/blood.v122.21.3727.3727.
Roa, Fernando, und Mariana Pires de Campos Telles. „The Cerrado (Brazil) plant cytogenetics database“. Comparative Cytogenetics 11, Nr. 2 (25.04.2017): 285–97. http://dx.doi.org/10.3897/compcytogen.11(2).11395.
Laughlin, M. J., D. S. McGaughey, J. R. Crews, N. J. Chao, D. Rizzieri, M. Ross, J. Gockerman et al. „Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant.“ Journal of Clinical Oncology 16, Nr. 3 (März 1998): 1008–12. http://dx.doi.org/10.1200/jco.1998.16.3.1008.
Schanz, Julie, Christian Steidl, Christa Fonatsch, Michael Pfeilstöcker, Thomas Nösslinger, Heinz Tuechler, Peter Valent et al. „Coalesced Multicentric Analysis of 2,351 Patients With Myelodysplastic Syndromes Indicates an Underestimation of Poor-Risk Cytogenetics of Myelodysplastic Syndromes in the International Prognostic Scoring System“. Journal of Clinical Oncology 29, Nr. 15 (20.05.2011): 1963–70. http://dx.doi.org/10.1200/jco.2010.28.3978.
Strand, Jacob J., Terra L. Lasho, Susan M. Schwager, Michelle M. Elliott, Chin-Yang Li und Ayalew Tefferi. „Cytogenetic Profile, JAK2V617F Mutational Status, and Response to Drug Therapy in Myelofibrosis with Myeloid Metaplasia.“ Blood 106, Nr. 11 (16.11.2005): 2591. http://dx.doi.org/10.1182/blood.v106.11.2591.2591.
Deerberg-Wittram, J., K. Weber-Matthiesen und B. Schlegelberger. „Cytogenetics and molecular cytogenetics in Hodgkin's disease“. Annals of Oncology 7 (1996): S49—S53. http://dx.doi.org/10.1093/annonc/7.suppl_4.s49.
Donnenfeld, Alan E., und Allen N. Lamb. „Cytogenetics and molecular cytogenetics in prenatal diagnosis“. Clinics in Laboratory Medicine 23, Nr. 2 (Juni 2003): 457–80. http://dx.doi.org/10.1016/s0272-2712(03)00024-6.
Liebisch, Peter, und Hartmut Döhner. „Cytogenetics and molecular cytogenetics in multiple myeloma“. European Journal of Cancer 42, Nr. 11 (Juli 2006): 1520–29. http://dx.doi.org/10.1016/j.ejca.2005.12.028.
Wang, Nancy. „Methodologies in cancer cytogenetics and molecular cytogenetics“. American Journal of Medical Genetics 115, Nr. 3 (24.10.2002): 118–24. http://dx.doi.org/10.1002/ajmg.10687.
D'Amato, Lucia. „Molecular Cytogenetics and its Applications to Soft Tissue Tumor Analysis“. Tumori Journal 81, Nr. 6 (November 1995): 395–98. http://dx.doi.org/10.1177/030089169508100601.
Liehr, T., V. Trifonov, A. Polityko, L. Brecevic, K. Mrasek, A. Weise, E. Ewers et al. „Characterization of Small Supernumerary Marker Chromosomes By A Simple Molecular and Molecular Cytogenetics Approach“. Balkan Journal of Medical Genetics 10, Nr. 1 (01.04.2007): 33–37. http://dx.doi.org/10.2478/v10034-007-0006-5.
Avet-Loiseau, Herve, Cyrille Hulin, Lofti Benboubker, Meletios A. Dimopoulos, Andrew Belch, Donna Reece, John Catalano et al. „Impact of Cytogenetics on Outcomes of Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Treated with Continuous Lenalidomide Plus Low-Dose Dexamethasone in the First (MM-020) Trial“. Blood 126, Nr. 23 (03.12.2015): 730. http://dx.doi.org/10.1182/blood.v126.23.730.730.
Marcucci, Guido, Krzysztof Mrózek, Amy S. Ruppert, Kellie J. Archer, Mark J. Pettenati, Nyla A. Heerema, Andrew J. Carroll et al. „Abnormal Cytogenetics at Date of Morphologic Complete Remission Predicts Short Overall and Disease-Free Survival, and Higher Relapse Rate in Adult Acute Myeloid Leukemia: Results From Cancer and Leukemia Group B Study 8461“. Journal of Clinical Oncology 22, Nr. 12 (15.06.2004): 2410–18. http://dx.doi.org/10.1200/jco.2004.03.023.
Heng, JL, YC Chen, TC Quah, TC Liu und AEJ Yeoh. „Dedicated Cytogenetics Factor is Critical for Improving Karyotyping Results for Childhood Leukaemias – Experience in the National University Hospital, Singapore 1989-2006“. Annals of the Academy of Medicine, Singapore 39, Nr. 2 (15.02.2010): 102–6. http://dx.doi.org/10.47102/annals-acadmedsg.v39n2p102.
Bhowmick, Biplab Kumar, und Sumita Jha. „A critical review on cytogenetics of Cucurbitaceae with updates on Indian taxa“. Comparative Cytogenetics 16, Nr. 2 (26.04.2022): 93–125. http://dx.doi.org/10.3897/compcytogen.v16.i2.79033.
Bhowmick, Biplab Kumar, und Sumita Jha. „A critical review on cytogenetics of Cucurbitaceae with updates on Indian taxa“. Comparative Cytogenetics 16, Nr. 2 (26.04.2022): 93–125. http://dx.doi.org/10.3897/compcytogen.v16.i2.79033.